JPMorgan Chase & Co. has increased its stake in American Healthcare REIT, Inc. (NYSE: AHR) by 4.3% during the third quarter of 2023, according to a recent filing with the Securities and Exchange Commission (SEC). The institutional investor now owns 468,716 shares of the company’s stock, having acquired an additional 19,273 shares during the quarter. This investment is valued at approximately $19.69 million, reflecting a holding of about 0.28% of American Healthcare REIT.
Several other institutional investors have also adjusted their positions in American Healthcare REIT recently. HighTower Advisors LLC increased its stake by 1.9%, bringing its total to 115,052 shares, worth $4.83 million. Florida Financial Advisors LLC entered a new position, investing around $623,000, while Balboa Wealth Partners purchased shares valued at $269,000. Notably, Metis Global Partners LLC raised its stake by 36.2%, owning now 35,956 shares valued at $1.51 million. Collectively, institutional investors and hedge funds hold 16.68% of the company’s stock.
American Healthcare REIT’s Current Stock Performance
As of Tuesday, shares of American Healthcare REIT opened at $52.88. The company boasts a market capitalization of $9.36 billion, with a price-to-earnings (P/E) ratio of 128.98. Its price-to-earnings-growth (PEG) ratio stands at 1.97 and it has a beta of 0.94. The firm’s financial ratios indicate a debt-to-equity ratio of 0.37, a current ratio of 0.44, and a quick ratio of 0.44. Over the past year, the stock has fluctuated between a low of $26.48 and a high of $54.67. The fifty-day moving average price is $48.91, while the 200-day moving average is $46.28.
In addition to stock performance, American Healthcare REIT recently announced a quarterly dividend of $0.25 per share, which was distributed on January 16, 2024. Shareholders on record as of December 31, 2023 received this dividend, representing an annualized amount of $1.00 and a yield of 1.9%. The company’s dividend payout ratio (DPR) currently stands at an elevated 243.90%.
Insider Transactions and Analyst Ratings
In related news, Director Jeffrey T. Hanson sold 35,570 shares of the company on December 22, 2023, at an average price of $48.38, resulting in proceeds of approximately $1.72 million. After this transaction, he retains 19,208 shares, valued at about $929,283. This sale represents a significant 64.93% reduction in his ownership of the stock. Company insiders now hold 1.00% of American Healthcare REIT.
Wall Street analysts have expressed optimism regarding the stock’s future performance. Scotiabank recently raised its target price for American Healthcare REIT from $47.00 to $55.00, assigning a “sector outperform” rating. Similarly, Morgan Stanley increased its target from $52.00 to $55.00, while KeyCorp also boosted its price objective to $55.00, granting an “overweight” rating. Analyst coverage indicates a strong consensus, with one rating the stock as a Strong Buy, nine as Buy, and three as Hold. Currently, the consensus rating is “Moderate Buy” with a target price of $52.92.
American Healthcare REIT, Inc. operates as a publicly traded real estate investment trust, focusing on acquiring, owning, and managing healthcare-related properties across the United States. Its portfolio includes senior housing communities, skilled nursing facilities, medical office buildings, and outpatient care centers, all designed to provide stable rental income through long-term lease agreements. By partnering with established healthcare operators, the company aims to capitalize on the growing demand for healthcare services tied to an aging population.
